Patents by Inventor Hagar GREIF

Hagar GREIF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MITOCHONDRIAL PROTEINS CONSTRUCTS AND USES THEREOF
    Publication number: 20190248846
    Abstract: Disclosed are novel fusion protein constructs comprising a functional mitochondrial protein, that can enter mitochondria within intact cells. Further disclosed are methods of treating mitochondrial disorders by the disclosed fusion proteins and compositions therefor.
    Type: Application
    Filed: April 25, 2019
    Publication date: August 15, 2019
    Inventors: Haya Lorberboum-Galski, Hagar Greif
  • Mitochondrial proteins constructs and uses thereof
    Patent number: 10287331
    Abstract: Disclosed are fusion protein constructs comprising a functional mitochondrial protein, that can enter mitochondria within intact cells. Further disclosed are methods of treating mitochondrial disorders by the disclosed fusion proteins and compositions therefor.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: May 14, 2019
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Haya Lorberboum-Galski, Hagar Greif
  • METHYLMALONYL COENZYME A MUTASE (MCM) FUSION CONSTRUCTS FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH MCM DEFICIENCY
    Publication number: 20190127724
    Abstract: The present invention provides compositions and methods relating to protein replacement therapy for the treatment of disorders associated with Methylmalonyl CoA Mutase.
    Type: Application
    Filed: April 12, 2017
    Publication date: May 2, 2019
    Inventors: Hagar Greif, Anat Feldman, Haya Galski-Lorberboum
  • MITOCHONDRIAL PROTEINS CONSTRUCTS AND USES THEREOF
    Publication number: 20160075745
    Abstract: Disclosed are novel fusion protein constructs comprising a functional mitochondrial protein, that can enter mitochondria within intact cells. Further disclosed are methods of treating mitochondrial disorders by the disclosed fusion proteins and compositions therefor.
    Type: Application
    Filed: April 10, 2014
    Publication date: March 17, 2016
    Inventors: Haya LORBERBOUM-GALSKI, Hagar GREIF